Postdoctoral training in Pediatric Clinical Pharmacology

儿科临床药理学博士后培训

• 批准号: 9113782
• 负责人: JOHANNES NICOLAAS VAN DEN ANKER
• 金额: $ 12.74万
• 依托单位: CHILDREN'S RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-05-01 至 2021-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9113782
• 关键词: Childhood; Clinical Pharmacology; post-doctoral training

 DESCRIPTION (provided by applicant): This new postdoctoral research training program in Pediatric Clinical Pharmacology is a natural enhancement of the Pediatric Clinical Pharmacology fellowship program at Children's National Medical Center. The already existing collaboration with the Office of Clinical Pharmacology at the FDA and the T32 training program in Clinical Pharmacology at Johns Hopkins University School of Medicine will be intensified, whereas a new collaboration with the T32 training program at the University of Maryland School of Pharmacy will be initiated to even further broaden the opportunities of trainees in the discipline of Pediatric and Adult Clinical Pharmacology. Trainees with a M.D., Pharm.D., and/or Ph.D. will enter the two-year program that is primarily housed at the Children's Research Institute of Children's National Medical Center (CNMC) in Washington, D.C. The focus of this program will be to encourage the involvement of promising young researchers who will focus their efforts on training and experience in the methods and actual conduct of basic, translational and/or clinical research in the area of Pediatric Clinical Pharmacology in order to provide them with all the necessary tools to become independent researchers in this important discipline and to become future leaders in Pediatric Clinical Pharmacology. A unique aspect of the training will be that basic, translational and clinical aspects will be approached as "team science". We expect to train 8 young very motivated researchers (4 MDs, 2 PharmDs and 2 PhDs). Each trainee will be carefully mentored through the program to ensure that he/she fully exploits the range of opportunities of the program.

 描述（由申请人提供）：这项新的儿科临床药理学博士后研究培训项目是儿童国家医学中心儿科临床药理学研究金项目的自然增强，该项目与 FDA 临床药理学办公室和 T32 已有合作。约翰霍普金斯大学医学院临床药理学培训项目将得到加强，而与马里兰大学药学院T32培训项目的新合作将进一步启动扩大儿科和成人临床药理学学科学员的机会 拥有医学博士、药学博士和/或博士学位的学员将进入主要在儿童研究所进行的为期两年的课程。位于华盛顿特区的国家医学中心（CNMC）。该计划的重点是鼓励有前途的年轻研究人员参与，他们将重点关注基础、转化和/或临床方法和实际行为的培训和经验。儿科临床药理学领域的研究，以便为他们提供所有必要的工具，成为这一重要学科的独立研究人员，并成为儿科临床药理学的未来领导者。培训的一个独特方面是基础性的、转化性的。我们希望培养 8 名积极进取的年轻研究人员（4 名医学博士、2 名药学博士和 2 名博士）。范围该计划的机会。